Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
出版年份 2019 全文链接
标题
Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-03
DOI
10.1038/s41571-019-0293-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting
- (2019) Hanna Karvonen et al. ONCOGENE
- A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors
- (2019) Malini Menon et al. Scientific Reports
- Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
- (2019) Harmen van Andel et al. LEUKEMIA
- First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
- (2019) Branimir I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
- (2019) Yuxuan Miao et al. CELL
- Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
- (2019) Anna M. Paczulla et al. NATURE
- A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer
- (2019) Zishuo Ian Hu et al. Cancer Medicine
- Wnt, Notch, and TGF-β Pathways Impinge on Hedgehog Signaling Complexity: An Open Window on Cancer
- (2019) Maria Pelullo et al. Frontiers in Genetics
- Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML
- (2018) Ronan T. Swords et al. BLOOD
- Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report
- (2018) Kayo Inoue et al. BMC CANCER
- A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
- (2018) Natalie Cook et al. BRITISH JOURNAL OF CANCER
- Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
- (2018) Michael Y. Choi et al. Cell Stem Cell
- Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma
- (2018) Johanna Bendell et al. CLINICAL CANCER RESEARCH
- Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors
- (2018) A Craig Lockhart et al. INVESTIGATIONAL NEW DRUGS
- A phase II study of itraconazole in biochemically recurrent prostate cancer.
- (2018) Mina Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy, Safety, and Comparison of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: A Systematic Review and Meta-Analysis
- (2018) Pingxing Xie et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia
- (2018) Ana Paula Zambuzi Cardoso Marsola et al. MEDICAL ONCOLOGY
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer stem cells: regulation programs, immunological properties and immunotherapy
- (2018) Dingxiao Zhang et al. SEMINARS IN CANCER BIOLOGY
- CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
- (2018) Yao Wang et al. OncoImmunology
- Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
- (2018) Yoshitaka Sekido Cancers
- The Hippo Pathway: Immunity and Cancer
- (2018) Zaid Taha et al. Cancers
- Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma
- (2018) John Lamar et al. Cancers
- Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results
- (2018) Jorge E. Cortes et al. AMERICAN JOURNAL OF HEMATOLOGY
- First-in-human phase 1 study of the PARP/tankyrase inhibitor 2X-121 (E7449) as monotherapy in patients with advanced solid tumors and validation of a novel drug response predictor (DRP) mRNA biomarker.
- (2018) Elizabeth Ruth Plummer et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of rovalpituzumab tesirine in patients With DLL3-expressing, ≥ 3rd line small cell lung cancer: Results from the phase 2 TRINITY study.
- (2018) David Paul Carbone et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Targeting Cancer Stemness in the Clinic: From Hype to Hope
- (2018) Caner Saygin et al. Cell Stem Cell
- Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
- (2018) Jorge E. Cortes et al. LEUKEMIA
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
- (2018) Yumeng Wang et al. Cell Reports
- Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells
- (2018) Venus Sosa Iglesias et al. Frontiers in Oncology
- Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
- (2017) N. Basset-Séguin et al. EUROPEAN JOURNAL OF CANCER
- Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
- (2017) Miroslava Didiasova et al. FASEB JOURNAL
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- PRKCI promotes immune suppression in ovarian cancer
- (2017) Sharmistha Sarkar et al. GENES & DEVELOPMENT
- Wnt5a promotes Frizzled-4 signalosome assembly by stabilizing cysteine-rich domain dimerization
- (2017) Zachary J. DeBruine et al. GENES & DEVELOPMENT
- Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues
- (2017) Lanqing Cao et al. HUMAN PATHOLOGY
- Cancer stem cells as targets for immunotherapy
- (2017) Amy S. Codd et al. IMMUNOLOGY
- PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine
- (2017) Xiaojun Shi et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)
- (2017) Shivaani Kummar et al. JOURNAL OF CLINICAL ONCOLOGY
- Wnt/beta-catenin pathway: modulating anticancer immune response
- (2017) Sachin Gopalkrishna Pai et al. Journal of Hematology & Oncology
- Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study
- (2017) J.T. Lear et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
- (2017) Charles M Rudin et al. LANCET ONCOLOGY
- A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
- (2017) Shumei Song et al. MOLECULAR CANCER THERAPEUTICS
- Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Paclitaxel in Lung Adenocarcinoma
- (2017) Katherine M. Morgan et al. MOLECULAR CANCER THERAPEUTICS
- Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC
- (2017) Mark J. McKeage et al. Targeted Oncology
- An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells
- (2017) Deyong Jia et al. Cell Death & Disease
- Repurposing itraconazole as an anticancer agent
- (2017) Hiroshi Tsubamoto et al. Oncology Letters
- VGLL4 targets a TCF4–TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
- (2017) Shi Jiao et al. Nature Communications
- Notch Shapes the Innate Immunophenotype in Breast Cancer
- (2017) Qiang Shen et al. Cancer Discovery
- Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non–Small Cell Lung Cancer
- (2017) Dennis O. Adeegbe et al. Cancer Discovery
- Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression
- (2017) Gregorio J. Petrirena et al. Oncotarget
- Pirfenidone normalizes the tumor microenvironment to improve chemotherapy
- (2017) Christiana Polydorou et al. Oncotarget
- Pirfenidone Inhibits Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway
- (2017) Wei-Jie Zou et al. MEDICAL SCIENCE MONITOR
- Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
- (2017) Liang Liu et al. Frontiers in Immunology
- A phase I study of IPI-926, a novel hedgehog pathway inhibitor, in patients (pts) with advanced or metastatic solid tumors.
- (2017) C. M. Rudin et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized phase II study of vismodegib (V), a hedgehog (HH) pathway inhibitor, combined with FOLFOX in patients (pts) with advanced gastric and gastroesophageal junction (GEJ) carcinoma: A New York Cancer Consortium led study.
- (2017) Deirdre Jill Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer
- (2017) Yinglong Zhang et al. Scientific Reports
- Verteporfin inhibits growth of human glioma in vitro without light activation
- (2017) Ahmad Al-Moujahed et al. Scientific Reports
- Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC)
- (2016) W. Messersmith et al. ANNALS OF ONCOLOGY
- Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI
- (2016) Puneet Agarwal et al. BLOOD
- The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis
- (2016) L. Astudillo et al. CANCER RESEARCH
- Overview of CDK9 as a target in cancer research
- (2016) Fatima Morales et al. CELL CYCLE
- Induction of Expandable Tissue-Specific Stem/Progenitor Cells through Transient Expression of YAP/TAZ
- (2016) Tito Panciera et al. Cell Stem Cell
- CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1
- (2016) Y. Lee et al. CLINICAL CANCER RESEARCH
- Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
- (2016) David Balli et al. CLINICAL CANCER RESEARCH
- A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer
- (2016) Shubham Pant et al. EUROPEAN JOURNAL OF CANCER
- Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis
- (2016) Wantae Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- A phase 1b study of the anti-cancer stem cell agent demcizumab (DEM) and gemcitabine (GEM) +/- nab-paclitaxel in patients with pancreatic cancer.
- (2016) Manuel Hidalgo et al. JOURNAL OF CLINICAL ONCOLOGY
- Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib
- (2016) J Yu et al. LEUKEMIA
- Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth
- (2016) Jie Huang et al. MOLECULAR CANCER THERAPEUTICS
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinoma
- (2016) Daniel W. Bowles et al. ORAL ONCOLOGY
- Cisplatin induces stemness in ovarian cancer
- (2016) Andrew Wiechert et al. Oncotarget
- Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
- (2016) Mina S. Ally et al. JAMA Dermatology
- Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment
- (2016) Simonetta Buglioni et al. OncoImmunology
- CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
- (2016) Meiou Dai et al. Scientific Reports
- Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
- (2015) Zhenling Deng et al. BMC IMMUNOLOGY
- Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study
- (2015) Ronan T. Swords et al. BRITISH JOURNAL OF HAEMATOLOGY
- Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
- (2015) Scott X. Atwood et al. CANCER CELL
- Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
- (2015) Hayley J. Sharpe et al. CANCER CELL
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
- (2015) Vicki Plaks et al. Cell Stem Cell
- A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
- (2015) E. G. Chiorean et al. CLINICAL CANCER RESEARCH
- Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
- (2015) M. Cioffi et al. CLINICAL CANCER RESEARCH
- Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours
- (2015) S.A. Piha-Paul et al. EUROPEAN JOURNAL OF CANCER
- Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
- (2015) Giles W. Robinson et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?
- (2015) Axel Schulenburg et al. Journal of Hematology & Oncology
- NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
- (2015) Erik Ames et al. JOURNAL OF IMMUNOLOGY
- Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody
- (2015) Lei Zhao et al. JOURNAL OF IMMUNOTHERAPY
- Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer
- (2015) Martin P Barr et al. Molecular Cancer
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia
- (2015) Yiting Lim et al. Science Translational Medicine
- Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches
- (2015) Qin Pan et al. STEM CELLS
- YAP and TAZ: a nexus for Hippo signaling and beyond
- (2015) Carsten Gram Hansen et al. TRENDS IN CELL BIOLOGY
- A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
- (2015) C Papayannidis et al. Blood Cancer Journal
- Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
- (2015) G. Wang et al. Cancer Discovery
- Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins
- (2015) Wenqi Wang et al. Cell Reports
- GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis
- (2015) Ritesh K. Srivastava et al. Oncotarget
- Inhibition of hedgehog signaling by GANT58 induces apoptosis and shows synergistic antitumor activity with AKT inhibitor in acute T cell leukemia cells
- (2014) Xiaoming Hou et al. BIOCHIMIE
- Somatic mutation as a mechanism of Wnt/ -catenin pathway activation in CLL
- (2014) L. Wang et al. BLOOD
- A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
- (2014) Shi Jiao et al. CANCER CELL
- Inhibiting Tankyrases Sensitizes KRAS-Mutant Cancer Cells to MEK Inhibitors via FGFR2 Feedback Signaling
- (2014) M. Schoumacher et al. CANCER RESEARCH
- Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells
- (2014) B. Wang et al. CANCER RESEARCH
- Hedgehog-GLI Signaling Inhibition Suppresses Tumor Growth in Squamous Lung Cancer
- (2014) L. Huang et al. CLINICAL CANCER RESEARCH
- Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
- (2014) E. J. Kim et al. CLINICAL CANCER RESEARCH
- A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral -Secretase Inhibitor PF-03084014
- (2014) W. A. Messersmith et al. CLINICAL CANCER RESEARCH
- Organoid cultures for the analysis of cancer phenotypes
- (2014) Norman Sachs et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma
- (2014) Ana De Jesus-Acosta et al. INVESTIGATIONAL NEW DRUGS
- A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
- (2014) Haihui Lu et al. NATURE CELL BIOLOGY
- RNF43 is frequently mutated in colorectal and endometrial cancers
- (2014) Marios Giannakis et al. NATURE GENETICS
- Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers
- (2014) Francesca Cottini et al. NATURE MEDICINE
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- TARGETING GLIOMA INITIATING CELLS IN GBM: ABTC-0904, A RANDOMIZED PHASE 0/II STUDY TARGETING THE SONIC HEDGEHOG-SIGNALING PATHWAY
- (2014) A. E. Sloan et al. NEURO-ONCOLOGY
- Down-Regulation of Gli Transcription Factor Leads to the Inhibition of Migration and Invasion of Ovarian Cancer Cells via Integrin β4-Mediated FAK Signaling
- (2014) Qi Chen et al. PLoS One
- Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/β-Catenin Signaling
- (2014) Andy J. Chien et al. PLoS One
- A New Strategy Using ALDHhigh-CD8+T Cells to Inhibit Tumorigenesis
- (2014) Huiyan Luo et al. PLoS One
- Dll4 Blockade Potentiates the Anti-Tumor Effects of VEGF Inhibition in Renal Cell Carcinoma Patient-Derived Xenografts
- (2014) Kiersten Marie Miles et al. PLoS One
- Role of cancer stem cell-associated inflammation in creating pro-inflammatory tumorigenic microenvironments
- (2014) Masahisa Jinushi OncoImmunology
- Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
- (2014) Rachel E Beard et al. Journal for ImmunoTherapy of Cancer
- -Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL
- (2013) D. Kaveri et al. BLOOD
- Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells
- (2013) Ingrid Espinoza et al. CANCER LETTERS
- Canonical Wnt Signaling Is Required for Pancreatic Carcinogenesis
- (2013) Y. Zhang et al. CANCER RESEARCH
- Capturing the mammalian Hippo: Elucidating its role in cancer
- (2013) Miki Nishio et al. CANCER SCIENCE
- Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
- (2013) Seog-Young Kim et al. CELLULAR SIGNALLING
- Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
- (2013) A. Gajjar et al. CLINICAL CANCER RESEARCH
- Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133high cancer stem cells in vitro and in vivo
- (2013) Jianhua Huang et al. CLINICAL IMMUNOLOGY
- Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2
- (2013) Tracy X. Cui et al. IMMUNITY
- A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors
- (2013) Ivan Diaz-Padilla et al. INVESTIGATIONAL NEW DRUGS
- A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)
- (2013) Suzanne Richter et al. INVESTIGATIONAL NEW DRUGS
- Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
- (2013) Andy C. Rawstron et al. JOURNAL OF CLINICAL ONCOLOGY
- Notch activation inhibits AML growth and survival: a potential therapeutic approach
- (2013) Sankaranarayanan Kannan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer
- (2013) Charles M. Rudin et al. Journal of Thoracic Oncology
- Unraveling the therapeutic potential of the Hedgehog pathway in cancer
- (2013) Dereck Amakye et al. NATURE MEDICINE
- Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer
- (2013) E. S. Antonarakis et al. ONCOLOGIST
- Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
- (2013) X. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells
- (2013) J Yun et al. Oncogenesis
- Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia
- (2012) Evgeny A Moskalev et al. BMC CANCER
- Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism
- (2012) Jennifer L. Allensworth et al. BREAST CANCER RESEARCH AND TREATMENT
- A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential
- (2012) Chung-Gi Lee et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genetic and Pharmacologic Inhibition of β-Catenin Targets Imatinib-Resistant Leukemia Stem Cells in CML
- (2012) Florian H. Heidel et al. Cell Stem Cell
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
- (2012) S. B. Kaye et al. CLINICAL CANCER RESEARCH
- A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
- (2012) J. Berlin et al. CLINICAL CANCER RESEARCH
- Stem-like Tumor-Initiating Cells Isolated from IL13R 2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine-Redirected T Cells
- (2012) C. E. Brown et al. CLINICAL CANCER RESEARCH
- Hedgehog Signaling in Hematopoiesis
- (2012) Yiting Lim et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- A phase II study of RO4929097 in metastatic colorectal cancer
- (2012) Jonathan R. Strosberg et al. EUROPEAN JOURNAL OF CANCER
- Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
- (2012) Richard A. Morgan et al. HUMAN GENE THERAPY
- Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
- (2012) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts
- (2012) Alexandre P.A. Theocharides et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Preclinical Analysis of the -Secretase Inhibitor PF-03084014 in Combination with Glucocorticoids in T-cell Acute Lymphoblastic Leukemia
- (2012) J. B. Samon et al. MOLECULAR CANCER THERAPEUTICS
- Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer
- (2012) A. D. Steg et al. MOLECULAR CANCER THERAPEUTICS
- Recurrent R-spondin fusions in colon cancer
- (2012) Somasekar Seshagiri et al. NATURE
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma
- (2012) Kinga A. Kocemba et al. PLoS One
- Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model
- (2012) M. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential niche and Wnt requirements during acute myeloid leukemia progression
- (2011) S. W. Lane et al. BLOOD
- Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
- (2011) K Pandya et al. BRITISH JOURNAL OF CANCER
- Vaccines Targeting Cancer Stem Cells
- (2011) Madhav V. Dhodapkar et al. CANCER JOURNAL
- Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity
- (2011) Miaorong She et al. CANCER LETTERS
- Targeting ALDHbright Human Carcinoma-Initiating Cells with ALDH1A1-Specific CD8+ T Cells
- (2011) C. Visus et al. CLINICAL CANCER RESEARCH
- Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
- (2011) H. Korkaya et al. CLINICAL CANCER RESEARCH
- Notch signaling: simplicity in design, versatility in function
- (2011) E. R. Andersson et al. DEVELOPMENT
- Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think: Table I.
- (2011) Camille Lobry et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma
- (2011) R R Singh et al. ONCOGENE
- Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
- (2011) M. R. Tanas et al. Science Translational Medicine
- Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
- (2010) Andrey I. Khramtsov et al. AMERICAN JOURNAL OF PATHOLOGY
- Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
- (2010) James Kim et al. CANCER CELL
- β-Catenin Mediates the Establishment and Drug Resistance of MLL Leukemic Stem Cells
- (2010) Jenny Yeung et al. CANCER CELL
- Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-Abl
- (2010) Mark A. Gregory et al. CANCER CELL
- Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
- (2010) T. Schatton et al. CANCER RESEARCH
- Tumor-Initiating Cells Are Rare in Many Human Tumors
- (2010) Kota Ishizawa et al. Cell Stem Cell
- Wnt/ -Catenin Signaling in T-Cell Immunity and Cancer Immunotherapy
- (2010) L. Gattinoni et al. CLINICAL CANCER RESEARCH
- Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
- (2010) T. Di Tomaso et al. CLINICAL CANCER RESEARCH
- Alternative Promoter Usage at the Notch1 Locus Supports Ligand-Independent Signaling in T Cell Development and Leukemogenesis
- (2010) Pablo Gómez-del Arco et al. IMMUNITY
- β-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice
- (2010) John P. Morris et al. JOURNAL OF CLINICAL INVESTIGATION
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
- (2010) Elspeth M. Beauchamp et al. JOURNAL OF CLINICAL INVESTIGATION
- Foxp3+ IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer
- (2010) Shaobo Yang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation
- (2010) Elizabeth A. Griffiths et al. LEUKEMIA & LYMPHOMA
- Evaluation of Selective -Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
- (2010) P. Wei et al. MOLECULAR CANCER THERAPEUTICS
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Glioma cancer stem cells induce immunosuppressive macrophages/microglia
- (2010) Adam Wu et al. NEURO-ONCOLOGY
- Hedgehog signaling maintains chemoresistance in myeloid leukemic cells
- (2010) K C S Queiroz et al. ONCOGENE
- Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells
- (2010) P Desch et al. ONCOGENE
- Paracrine Hedgehog Signaling in Cancer
- (2009) J.-W. Theunissen et al. CANCER RESEARCH
- Role of Notch signaling in colorectal cancer
- (2009) L. Qiao et al. CARCINOGENESIS
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia
- (2009) A Valencia et al. LEUKEMIA
- Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-Cell lymphoma
- (2009) Ji Eun Kim et al. MODERN PATHOLOGY
- Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
- (2009) Bin-Bing S. Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
- (2009) Charles M. Rudin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
- (2009) L Yang et al. ONCOGENE
- Alterations of the Notch pathway in lung cancer
- (2009) Britta Westhoff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens
- (2009) Qijin Xu et al. STEM CELLS
- Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation
- (2008) Christine Dierks et al. CANCER CELL
- Cancer stem cells – old concepts, new insights
- (2008) L Vermeulen et al. CELL DEATH AND DIFFERENTIATION
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- Hedgehog-Induced Survival of B-Cell Chronic Lymphocytic Leukemia Cells in a Stromal Cell Microenvironment: A Potential New Therapeutic Target
- (2008) G. V. Hegde et al. MOLECULAR CANCER RESEARCH
- Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation
- (2008) Wei Guo et al. NATURE
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
- (2008) Catherine D. Van Raamsdonk et al. NATURE
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
- Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
- (2008) M. Marzec et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search